Cargando…
Considerations for setting occupational exposure limits for novel pharmaceutical modalities
In order to develop new and effective medicines, pharmaceutical companies must be modality agnostic. As science reveals an enhanced understanding of biological processes, new therapeutic modalities are becoming important in developing breakthrough therapies to treat both rare and common diseases. As...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605856/ https://www.ncbi.nlm.nih.gov/pubmed/33144077 http://dx.doi.org/10.1016/j.yrtph.2020.104813 |